We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$93.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$64.9M
3
AMZN icon
Amazon
AMZN
+$58.3M
4
SYK icon
Stryker
SYK
+$56.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$49.9M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QVCGA
151
DELISTED
QVC Group Inc Series A
QVCGA
$13.9M 0.14%
11,712
-6,440
-35% -$7.47M
MANU icon
152
Manchester United
MANU
$3.91B
$13.4M 0.14%
+666,196
New +$12.8M
AVGO icon
153
Broadcom
AVGO
$1.82T
$12.9M 0.13%
500,130
-237,420
-32% -$6.17M
TSRO
154
DELISTED
TESARO, Inc.
TSRO
$11.6M 0.12%
140,000
+60,000
+75% +$5.88M
CBIO
155
Crescent Biopharma
CBIO
$602M
$11.4M 0.12%
+6,793
New +$8.98M
TSLA icon
156
Tesla
TSLA
$1.24T
$11.4M 0.12%
549,435
+255,435
+87% +$5.56M
ARCC icon
157
Ares Capital
ARCC
$13.5B
$11.3M 0.12%
716,732
+100,000
+16% +$1.62M
FRC
158
DELISTED
First Republic Bank
FRC
$11.1M 0.11%
128,271
+9,661
+8% +$915K
SIVB
159
DELISTED
SVB Financial Group
SIVB
$10.9M 0.11%
46,761
-1,095
-2% -$233K
PPLI
160
People Inc
PPLI
$3.1B
$10.8M 0.11%
494,002
+152,581
+45% +$3.42M
AUPH icon
161
Aurinia Pharmaceuticals
AUPH
$1.97B
$10.4M 0.11%
2,300,000
+681,648
+42% +$3.78M
RVTY icon
162
Revvity
RVTY
$12.3B
$10.4M 0.11%
141,887
– –
BX icon
163
Blackstone
BX
$104B
$10.2M 0.11%
319,380
+27,159
+9% +$884K
KEY icon
164
KeyCorp
KEY
$24.3B
$10.2M 0.11%
506,109
+75,275
+17% +$1.42M
MA icon
165
Mastercard
MA
$477B
$10.1M 0.1%
66,854
+298
+0.4% +$44.3K
SLRC icon
166
SLR Investment Corp
SLRC
$706M
$9.97M 0.1%
493,278
+67,000
+16% +$1.43M
PRLB icon
167
Protolabs
PRLB
$1.86B
$9.9M 0.1%
96,085
+30,516
+47% +$2.74M
PFLT icon
168
PennantPark Floating Rate Capital
PFLT
$681M
$9.4M 0.1%
685,000
+129,250
+23% +$1.82M
TTWO icon
169
Take-Two Interactive
TTWO
$43B
$8.53M 0.09%
77,691
+1,598
+2% +$174K
PPBI
170
DELISTED
Pacific Premier Bancorp
PPBI
$8.2M 0.08%
204,904
+759
+0.4% +$29.9K
AET
171
DELISTED
Aetna Inc
AET
$8.15M 0.08%
45,122
-382,154
-89% -$65.7M
BSX icon
172
Boston Scientific
BSX
$65.8B
$8.11M 0.08%
327,000
+22,734
+7% +$627K
SUPN icon
173
Supernus Pharmaceuticals
SUPN
$2.68B
$7.97M 0.08%
200,000
-138,956
-41% -$5.49M
ONC
174
BeOne Medicines Ltd
ONC
$33.8B
$7.82M 0.08%
80,000
+5,000
+7% +$458K
APTV icon
175
Aptiv
APTV
$12B
$7.52M 0.08%
+88,679
New +$8.44M
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.